Key result
TAVR explantation is increasingly needed for aortic stenosis patients outliving prostheses unsuitable for redo procedures.
Why the study?
As TAVR indications expand to younger patients likely to outlive their prostheses, THV explantation techniques are increasingly relevant for lifetime aortic stenosis management.
Surgical explantation of transcatheter heart valves may be required in the lifetime management of aortic stenosis when redo TAVR is not feasible.
Transcatheter heart valve (THV) explantation is increasingly relevant as indications for transcatheter aortic valve replacement (TAVR) expand to patients who will likely outlive their prostheses and require reintervention.1 Redo TAVR is not feasible for all patients, and explantation may be required in the lifetime management of aortic stenosis.
No takes yet. Share an insight, caveat, or question.
Saleh et al. (2026) studied this question. Transcatheter heart valve explantation is increasingly required in the lifetime management of aortic stenosis for patients who outlive their prostheses and cannot undergo redo procedures.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: